Corey Michael Watton, a director at ZeVRA Therapeutics Inc. ($ZVRA), made one open market purchase of common shares worth $2,352 in the last year. His most recent buy occurred on March 28, 2025. This ranks him 4,736th out of 4,983 insiders by purchase amount, below the average of $1.46 million across 3.29 transactions per insider. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Watton Corey Michael | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 47,808,817 | 9999.99% | 0.06% |
| March 28, 2025 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Watton Corey Michael | Director | P | Common Stock | 300 | $7.84 | 1,800.0000 | 47,808,817 | 20.00% | 0.00% |
| Oct. 11, 2024 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Watton Corey Michael | Director | P | Common Stock | 500 | $7.92 | 1,500.0000 | 47,808,817 | 50.00% | 0.00% |
| May 13, 2024 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Watton Corey Michael | Director | A | Stock Option (right to buy) | 39200 | $0.00 | 39,200.0000 | 0 | 9999.99% | 0.00% |
| June 23, 2023 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Watton Corey Michael | Director | P | Common Stock | 275 | $5.95 | 1,000.0000 | 0 | 37.93% | 0.00% |
| June 9, 2023 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Watton Corey Michael | Director | P | Common Stock | 325 | $5.52 | 1,125.0000 | 0 | 40.63% | 0.00% |
| May 30, 2023 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Watton Corey Michael | Director | P | Common Stock | 400 | $5.11 | 400.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2023 | ZEVRA THERAPEUTICS, INC. | $ZVRA | Watton Corey Michael | Director | A | Stock Option (right to buy) | 58800 | $0.00 | 58,800.0000 | 0 | 9999.99% | 0.00% |